Reliant AI, a new AI-powered data analytics software, has received €10.1 million in seed funding and is targeting the biopharma industry. The company’s first product, Reliant Tabular, uses generative AI to help life science analysts find scientific evidence for their decisions through automated systematic reviews and comprehensive analyses.